Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 40, 2021 - Issue 5
198
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Lacrimal drainage apparatus melanoma remotely following treatment and resolution of conjunctival melanoma

ORCID Icon, , , , , , , , & show all
Pages 423-430 | Received 16 Jun 2020, Accepted 05 Aug 2020, Published online: 18 Aug 2020

References

  • Shields J, Eyelid SC. Conjunctival, and Orbital Tumors: An Atlas and Textbook. Philadelphia: Lippincott, Williams, and Wilkins; 2008:233–242.
  • Stefanyszyn MA, Hidayat AA, Peʼer JJ, Flanagan JC, et al. Lacrimal sac tumors. Ophthalmic Plast Reconstr Surg. 1994;10(3):169–184. doi:10.1097/00002341-199409000-00005.
  • Pujari A, Ali MJ, Mulay K, Naik MN, Honavar SG, et al. The black lacrimal sac: a clinicopathological correlation of a malignant melanoma with anterior lacrimal crest infiltration. Int Ophthalmol. 2014;34(1):111–115. doi:10.1007/s10792-013-9743-5.
  • Paridaens AD, McCartney AC, Lavelle RJ, Hungerford JL, et al. Nasal and orbital recurrence of conjunctival melanoma 21 years after exenteration. Br J Ophthalmol. 1992;76(6):369–371. doi:10.1136/bjo.76.6.369.
  • Missotten GS, Gambrelle J, de Wolff-rouendaal D, de Keizer RJW, et al. Epistaxis or epiphora as a sign for extension of a conjunctival melanoma. A series of six patients with nasolacrimal recurrence. Br J Ophthalmol. 2010;94(10):1328–1331. doi:10.1136/bjo.2009.168823.
  • Satchi K, McKelvie P, McNab AA. Malignant melanoma of the lacrimal drainage apparatus complicating conjunctival melanoma. Ophthalmic Plast Reconstr Surg. 2015;31(3):207–210. doi:10.1097/IOP.0000000000000256.
  • Shehata M, Gombos D, Bishop J, Zafereo ME, et al. Sinonasal melanoma arising from conjunctival primary acquired melanosis. BMJ Case Rep. 2015;2015(feb18 1):bcr2014208522–bcr2014208522. doi:10.1136/bcr-2014-208522.
  • Rao R, Honavar SG, De Padua M, Mulay K, Reddy VP, et al. Melanorrhea: noncontiguous spread of palpebral conjunctival melanoma to the nasolacrimal duct. Indian J Ophthalmol. 2018;66(2):302–303. doi:10.4103/ijo.IJO_886_17.
  • Shields CL, Markowitz JS, Belinsky I, Schwartzstein H, George NS, Lally SE, et al. Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology. 2011;118(2):389–395.e381-382. doi:10.1016/j.ophtha.2010.06.021.
  • Shields CL, Yaghy A, Dalvin LA, et al. Conjunctival melanoma: features and outcomes based on the fitzpatrick skin type in 540 patients at a single ocular oncology center. Ophthalmic Plast Reconstr Surg. 2020;in press.
  • Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am Ophthalmol Soc. 2000;98:471–492.
  • Robertson DM, Hungerford JL, McCartney A. Malignant melanomas of the conjunctiva, nasal cavity, and paranasal sinuses. Am J Ophthalmol. 1989;108(4):440–442. doi:10.1016/S0002-9394(14)73314-8.
  • Weiss JS, Perusse P, Reale F. Tear cytology in conjunctival melanoma. Am J Ophthalmol. 1991;111(5):648–649. doi:10.1016/S0002-9394(14)73716-X.
  • Jakobiec FA, Stagner AM, Sutula FC, Freitag SK, Yoon MK, et al. Pigmentation of the lacrimal sac epithelium. Ophthalmic Plast Reconstr Surg. 2016;32(6):415–423. doi:10.1097/IOP.0000000000000541.
  • Damato B, Coupland SE. An audit of conjunctival melanoma treatment in Liverpool. Eye (Lond). 2009;23(4):801–809. doi:10.1038/eye.2008.154.
  • Gökmen Soysal H, Ardiç F. Malignant conjunctival tumors invading the orbit. Ophthalmologica. 2008;222(5):338–343. doi:10.1159/000146079.
  • Kumar VA, Esmaeli B, Ahmed S, Gogia B, Debnam JM, Ginsberg LE, et al. Imaging features of malignant lacrimal sac and nasolacrimal duct tumors. AJNR Am J Neuroradiol. 2016;37(11):2134–2137. doi:10.3174/ajnr.A4882.
  • Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years’ experience. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1108–1114. doi:10.1007/s00417-004-1080-y.
  • Pe’er J, Frucht-Pery J. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. Am J Ophthalmol. 2005;139(2):229–234. doi:10.1016/j.ajo.2004.08.065.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.